Translational Development Acquisition Stock Price, News & Analysis

TDAC NASDAQ

Company Description

Welcome to the overview page for Translational Development Acquisition (TDAC), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

4.2 %

Performance 1 year

$228.5M

Market Cap

21.9M

Shares outstanding

Latest News

View All

June 30, 2021

4.73%

Trident Acquisitions Corp. Files 10-Q and is in Compliance with Nasdaq Reporting Rules

acquisition

June 25, 2021

0.59%

Trident Acquisitions Corp. Files 10K/A

acquisition

June 2, 2021

0.72%

Trident Acquisitions Corp. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

acquisition

May 21, 2021

1.03%

Trident Acquisitions Announces Filing of Proxy Supplement in Connection With Its Stockholder Proposal to Extend Period to Consummate Business Combination

acquisition

April 28, 2021

3.64%

Lottery.com Hosts Investor Webcast in Connection with its Previously Announced Business Combination with Trident Acquisitions Corp.

acquisition

February 26, 2021

4.26%

Trident Acquisitions Announces Board Approval to Extend Period to Consummate Business Combination

acquisition

SEC Filings

View All

October 10, 2025

[SCHEDULE 13G/A] Translational Development Acquisition Corp. SEC Filing

Financial Highlights

$4,294,488

Net Income (TTM)

-$194,805

Operating Cash Flow

0.02

Current Ratio

-$590,217

Operating Income

—

Revenue (TTM)

—

Diluted EPS (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Translational Development Acquisition (TDAC)?

The current stock price of Translational Development Acquisition (TDAC) is $10.43 as of November 14, 2025.

What is the market cap of Translational Development Acquisition (TDAC)?

The market cap of Translational Development Acquisition (TDAC) is approximately 228.5M. Learn more about what market capitalization means .

What is the net income of Translational Development Acquisition (TDAC)?

The trailing twelve months (TTM) net income of Translational Development Acquisition (TDAC) is $4,294,488.

What is the operating cash flow of Translational Development Acquisition (TDAC)?

The operating cash flow of Translational Development Acquisition (TDAC) is -$194,805. Learn about cash flow.

What is the current ratio of Translational Development Acquisition (TDAC)?

The current ratio of Translational Development Acquisition (TDAC) is 0.02, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Translational Development Acquisition (TDAC)?

The operating income of Translational Development Acquisition (TDAC) is -$590,217. Learn about operating income.